What is a stock summary page? Click here for an overview.
Business Description
Terns Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US8808811074
Share Class Description:
STU:430: Ordinary SharesDescription
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 265.9 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 20.3 | |||||
| 3-Year FCF Growth Rate | 22 | |||||
| 3-Year Book Growth Rate | -14.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -9.45 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.68 | |||||
| 9-Day RSI | 13.61 | |||||
| 14-Day RSI | 18.02 | |||||
| 3-1 Month Momentum % | -38.72 | |||||
| 6-1 Month Momentum % | -53.93 | |||||
| 12-1 Month Momentum % | -33.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 23.14 | |||||
| Quick Ratio | 23.14 | |||||
| Cash Ratio | 22.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -51.1 | |||||
| Shareholder Yield % | -88.97 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -31.26 | |||||
| ROA % | -29.85 | |||||
| ROIC % | -1535.51 | |||||
| 3-Year ROIIC % | -771.49 | |||||
| ROC (Joel Greenblatt) % | -9139.69 | |||||
| ROCE % | -35.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.5 | |||||
| Price-to-Tangible-Book | 0.49 | |||||
| EV-to-EBIT | 1.8 | |||||
| EV-to-Forward-EBIT | -0.07 | |||||
| EV-to-EBITDA | 1.82 | |||||
| EV-to-Forward-EBITDA | -0.07 | |||||
| EV-to-FCF | 2.49 | |||||
| Price-to-Net-Current-Asset-Value | 0.5 | |||||
| Price-to-Net-Cash | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 55.65 | |||||
| FCF Yield % | -39.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Terns Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.045 | ||
| Beta | -1.6 | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.83 | ||
| Volatility % | 59.97 | ||
| 14-Day RSI | 18.02 | ||
| 14-Day ATR (€) | 0.144411 | ||
| 20-Day SMA (€) | 2.761 | ||
| 12-1 Month Momentum % | -33.86 | ||
| 52-Week Range (€) | 1.79 - 10 | ||
| Shares Outstanding (Mil) | 87.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Terns Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Terns Pharmaceuticals Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Terns Pharmaceuticals Inc Frequently Asked Questions
What is Terns Pharmaceuticals Inc(STU:430)'s stock price today?
The current price of STU:430 is €1.79. The 52 week high of STU:430 is €10.00 and 52 week low is €1.79.
When is next earnings date of Terns Pharmaceuticals Inc(STU:430)?
The next earnings date of Terns Pharmaceuticals Inc(STU:430) is 2025-05-13 Est..
Does Terns Pharmaceuticals Inc(STU:430) pay dividends? If so, how much?
Terns Pharmaceuticals Inc(STU:430) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers